A maker of quantum computers, Quantinuum builds both the machines and the software that run on them. Its trapped-ion systems, the H-Series, tackle complex problems in fields like drug discovery, materials science, and secure communications. The company formed in 2021 when Honeywell's quantum hardware division merged with the U.K. software startup Cambridge Quantum, and its name blends "quantum" with "continuum." Its machines literally shuttle individual atomic ions around the chip like tiny taxis, and they've even demonstrated quantum teleportation.
Quantinuum's Q2 operating loss widened to $555M, driven by a $447.5M one-time IPO stock compensation charge.
The IPO left a deep mark on the income statement. rose 279% to $8.0 million, but a one-time, non-cash stock compensation charge of $447.5 million pushed the operating loss to $555.0 million. The company is now capitalized with $2.1 billion in cash, shifting the focus to execution against an unproven technology roadmap.
Key takeaways
The $555.0 million operating loss was overwhelmingly driven by a $447.5 million one-time, non-cash stock compensation expense triggered by the company's IPO.
rose 279% to $8.0 million, driven by higher cloud platform, research, and support services.
The loss on the change in fair value of grew to $47.6 million from $6.4 million a year ago, a non-cash adjustment.
Cash and cash equivalents stood at $2.1 billion as of June 30, 2026, after the company received $1.63 billion in net IPO proceeds.
Customer concentration remains a risk: one customer accounted for 16% of first-half and the U.S. government accounted for 29%.
A non-binding Letter of Intent with the Department of Commerce outlines a potential $100 million CHIPS Act award, contingent on definitive agreements and milestones.
What to watch
Whether the non-binding $100 million CHIPS Act Letter of Intent progresses to a definitive agreement with milestone-based funding.
growth trajectory now that the IPO is complete and the company is fully funded, to gauge commercial adoption of its quantum platform.
Any new customer concentration or diversification, given the current reliance on a single customer for 16% of and the U.S. government for 29%.
Section summaries
Management's Discussion and Analysis
Q2 2026 net loss widened to $596.5M driven by $447.5M in one-time IPO-related stock compensation, while revenue rose 279% to $8.0M.
⌄
-net increased $5.9M (279%) to $8.0M for Q2 2026, primarily from higher cloud platform, research, and support services.
Total costs and expenses surged $509.8M (958%) to $563.0M, overwhelmingly due to a $447.5M one-time, non-recurring stock compensation expense triggered by the IPO.
Operating expense levels excluding one-time IPO charges, to establish a baseline for the ongoing cash burn rate.
Research and development expenses-net rose $327.6M (826%), reflecting the IPO stock charge and increased investment in next-generation quantum systems.
Loss on change in fair value of grew to $47.6M from $6.4M, driven by adjustments.
Cash and cash equivalents stood at $2.1B as of June 30, 2026, bolstered by $1.63B in net IPO proceeds, and are deemed sufficient to fund operations for at least 12 months.
A non-binding Letter of Intent with the Department of Commerce outlines a potential $100M CHIPS Act award, subject to definitive agreements and milestone achievements.
We are currently involved in, and may in the future from time to time become involved in, legal proceedings, claims, and investigations in the ordinary course of our business. Although the results of these legal proceedings, claims, and investigations cannot be predicted with ce…
⌄
We are currently involved in, and may in the future from time to time become involved in, legal proceedings, claims, and investigations in the ordinary course of our business. Although the results of these legal proceedings, claims, and investigations cannot be predicted with certainty, we do not believe that the final outcome of any matters that we are currently involved in are reasonably likely to have a material adverse effect on our business, financial condition, or results of operations. Regardless of final outcomes, however, any such proceedings, claims, and investigations may nonetheless impose a significant burden on management and employees and be costly to defend, with unfavorable preliminary or interim rulings.
Quantinuum faces material risks as an early-stage quantum computing company, including uncertain path to fault-tolerant systems, history of losses, and reliance on a few customers.
⌄
Achieving commercially viable, involves substantial scientific uncertainty and may require breakthroughs that never occur, risking the entire business model.
The company has a history of significant losses ($632.2M operating loss in H1 2026) and expects to continue incurring losses for the near future with an unproven business model.
is highly concentrated, with one customer (RIKEN) accounting for 16% of H1 2026 revenue and the U.S. government accounting for 29%, making results susceptible to single-customer disruptions.
A National Security Agreement (NSA) with CFIUS imposes indefinite operational restrictions on hiring, vendor selection, and international expansion, creating a competitive disadvantage versus peers not subject to such agreements.
The proposed U.S. Government Transaction under the CHIPS Act is non-binding and subject to milestone-based funding, with risks of , , and uncertain financial and tax treatment.
The company is dependent on single-source and limited suppliers for specialized components like ion traps and isotopically enriched materials, exposing it to significant supply chain disruption risks.